Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin
Nicole Exner(Center for Integrated Protein Science Munich), Christian Haass(German Center for Neurodegenerative Diseases), Andreas S. Reichert(Düsseldorf University Hospital), Bettina Schmid(Center for Integrated Protein Science Munich), Suzana Gispert(Goethe University Frankfurt), Bettina Treske(Center for Integrated Protein Science Munich), Carola Schiesling(Hertie Institute for Clinical Brain Research), Georg Auburger(Goethe University Frankfurt), Thomas Gasser(Hertie Institute for Clinical Brain Research), Hans-Hermann Hoepken(Goethe University Frankfurt), Iria Carballo‐Carbajal(Hertie Institute for Clinical Brain Research), Kira M. Holmström(Herantis Pharma (Finland)), Konstanze F. Winklhofer(Unknown), Philipp J. Kahle(Siemens (Germany)), Frank Vogel(Max Delbrück Center), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Rejko Krüger(Centre Hospitalier de Luxembourg), Dominik Paquet(LMU Klinikum)
Cited by 512
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k